B

Beactica Therapeutics

16 employees

Beactica Therapeutics is a precision oncology company developing novel small molecule therapeutics to treat genetically defined cancers.

Basic info

Industry

pharmaceuticals

Sectors

Allosteric Modulators
Oncology
PROTACs
Drug Discovery
Interaction Analysis
Fragment-Based Drug Discovery
Health Care
Surface Plasmon Resonance (SPR)
Therapeutics
Medical
Kinetics
Mechanism of action

Date founded

2006

Funding rounds raised

Total raised

$957K

from 11 investors over 11 rounds

B

Beactica Therapeutics raised undisclosed on June 4, 2019

Investors: Almi Invest and Unionen

B

Beactica Therapeutics raised undisclosed on August 28, 2018

Investors: Unionen and Almi Invest

B

Beactica Therapeutics raised $88K on April 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

B

Beactica Therapeutics raised $240K on November 22, 2017

Investors: VINNOVA

B

Beactica Therapeutics raised undisclosed on December 15, 2014

Investors: Almi Invest

B

Beactica Therapeutics raised $405K on November 20, 2014

Investors: VINNOVA

B

Beactica Therapeutics raised $957K on February 22, 2011

Investors: European Commission

B

Beactica Therapeutics raised $590K on August 9, 2010

Investors: European Commission

B

Beactica Therapeutics raised undisclosed on April 2, 2007

Investors: VINNOVA

FAQ